| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kura Oncology, Inc. | Chief Scientific Officer | Common Stock | 32,424 | $274,329 | $8.46 | 27 Jan 2026 | Direct |
| Kura Oncology, Inc. | Chief Scientific Officer | Option to purchase common stock | 185,000 | 02 Jan 2026 | Direct | ||
| Kura Oncology, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 0 | 18 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | 27 Jan 2026 | 1 | -$11,092 | 4 | Chief Scientific Officer | 27 Jan 2026, 21:35 |
| KURA | Kura Oncology, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Scientific Officer | 06 Jan 2026, 16:30 |
| KURA | Kura Oncology, Inc. | 18 Dec 2025 | 3 | -$63,931 | 4 | Chief Scientific Officer | 19 Dec 2025, 16:30 |
| KURA | Kura Oncology, Inc. | 28 Jan 2025 | 2 | -$17,051 | 4 | Chief Scientific Officer | 28 Jan 2025, 20:38 |
| KURA | Kura Oncology, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Chief Scientific Officer | 07 Jan 2025, 17:32 |
| KURA | Kura Oncology, Inc. | 02 Jan 2025 | 0 | $0 | 3 | Chief Scientific Officer | 07 Jan 2025, 17:25 |